We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

GE Healthcare Offers Fast Trak Training in Singapore

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

GE Healthcare has announced that it is to begin offering Fast Trak training in a facility at the School of Life Sciences and Chemical Technology, Ngee Ann Polytechnic, Singapore.

GE Healthcare’s Fast Trak Training and Education Courses provide hands-on practical training in the latest technologies and strategies for bioprocessing, and are specifically designed to help biopharmaceutical manufacturers bring their product to market faster.

GE Healthcare’s Fast Trak Training & Education team has over 20 years’ experience in providing training for bioprocess development and manufacturing.

The scheme is unique in the life sciences sector in that it offers training that covers the whole of the downstream bioprocessing workflow.

GE Healthcare currently has Fast Trak Training Centres in China, Germany, India, Japan and the US, each equipped with the latest technologies for bioprocessing, in an environment that closely replicates the industrial setting.

The Singapore centre will provide easier access to training for scientists and production specialists based in the established markets of Australia and New Zealand, whilst also serving the rapidly growing markets of South East Asia, including Malaysia, Thailand and South Korea.

Olivier Loeillot, General Manager of Enterprise Solutions, GE Healthcare Life Sciences, said: “Establishing a Fast Trak Training presence in Singapore will bring us closer to our customers in South East Asia and Australasia. We can now offer our comprehensive training programmes in a more convenient location for the region’s rapidly developing biopharmaceutical manufacturing industry.”